(1) (a) The opiate antagonist bulk purchase fund, referred to in this section as the "fund", is hereby created in the state treasury. The fund consists of payments made to the department by participating eligible entities for the purchase of opiate antagonists; gifts, grants, and donations credited to the fund pursuant to subsection (1)(b) of this section; and any money that the general assembly may appropriate or transfer to the fund.
The department may seek, accept, and expend gifts, grants, or donations from privateor public sources for the purposes of this section. The department shall transmit all money received through gifts, grants, or donations to the state treasurer, who shall credit the money to the fund.
The state treasurer shall credit all interest and income derived from the deposit andinvestment of money in the fund to the fund.
Money in the fund is continuously appropriated to the department for bulk purchasing of opiate antagonists. Eligible entities may purchase opiate antagonists from the department. The department may contract with a prescription drug outlet, as defined in section 12-280-103 (43), for the bulk purchasing and distribution of opiate antagonists. The department shall provide technical assistance to participating eligible entities to ensure that eligible entities complete all training and registration requirements.
The department shall promulgate rules specifying the amount an eligible entity mustpay to purchase opiate antagonists from the department.
(a) No later than October 1, 2020, and every October 1 thereafter, the executive director of the department or the executive director's designee shall report to the house and senate appropriations committees, or their successor committees, on the fund's activity. The report must include:
Revenue received by the fund;
Revenue and expenditure projections for the forthcoming fiscal year and details ofall expenditures from the fund;
The eligible entities that purchased opiate antagonists;
The amount of opiate antagonists purchased by each eligible entity; and(V) The discount procured through bulk purchasing.
(b) Notwithstanding section 24-1-136 (11)(a)(I), the report required in this subsection (4) continues indefinitely.
(5) As used in this section, "eligible entity" means:
A unit of local government, as defined in section 29-3.5-101 (4);
A person making an opiate antagonist available pursuant to section 25-20.5-1001; or
The following entities, if the entity has adopted a policy allowing the acquisition,maintenance, and administration of opiate antagonists pursuant to section 22-1-119.1: (I) A school district board of education of a public school;
(II) The state charter school institute for an institute charter school; or (III) A governing board of a nonpublic school.
Source: L. 2019: Entire section added, (SB 19-227), ch. 273, p. 2580, § 10, effective May 23.